Luminex (NASDAQ:LMNX)
Historical Stock Chart
From Jul 2019 to Jul 2024
Luminex Corporation (NASDAQ:LMNX) today announced that it expects to
report first quarter results on Thursday, May 8, 2008. Results are
scheduled for release after the close of trading.
Management will hold a conference call to discuss the operating
highlights and financial results for the first quarter ended March 31,
2008, on May 8, 2008, at 5:00 p.m. Eastern time.
The conference call will be webcast live and will be accompanied by a
slide presentation, both of which may be accessed at Luminex
Corporation's website at http://www.luminexcorp.com.
Simply log on to the web at the address above, go to the Company section
and access the Investor Relations link. Please go to the website at
least 15 minutes prior to the call to register, download and install any
necessary audio/video software. If you are unable to participate during
the live webcast, the call and slides will be archived for one year on
the website using the 'replay' link.
The use of pop-up blocking software may impair your ability to view
webcasts. If you use this software, press and hold the CTRL key when you
click on the Register button. Please contact your IT group if you are
unable to override this feature. Unauthorized recording or downloading
of this event is not permitted.
Luminex Corporation develops, manufactures and markets proprietary
biological testing technologies with applications throughout the life
sciences industry. The Company's xMAP® system
is an open-architecture, multi-analyte technology platform that delivers
fast, accurate and cost-effective bioassay results to markets as diverse
as pharmaceutical drug discovery, clinical diagnostics and biomedical
research, including the genomics and proteomics research markets. The
Company's xMAP® technology is sold worldwide
and is in use in leading research laboratories as well as major
pharmaceutical, diagnostic and biotechnology companies. Further
information on Luminex Corporation or xMAP®
can be obtained on the Internet at http://www.luminexcorp.com.
Statements made in this release that express Luminex's or
management's intentions, plans, beliefs, expectations or predictions of
future events are forward-looking statements. The words "believe,"
"expect," "intend," "estimate," "anticipate," "will," "could," "should"
and similar expressions are intended to further identify such
forward-looking statements for purposes of the Private Securities
Litigation Reform Act of 1995. It is important to note that the
Company's actual results or performance could differ materially from
those anticipated or projected in such forward-looking statements.
Factors that could cause Luminex's actual results or performance to
differ materially include risks and uncertainties relating to, among
others, market demand and acceptance of Luminex's products, the
Company's dependence on strategic partners for development,
commercialization and distribution of products, concentration of the
Company's revenue in a limited number of strategic partners,
fluctuations in quarterly results due to a lengthy and unpredictable
sales cycle and bulk purchases of consumables, Luminex's ability to
scale manufacturing operations and manage operating expenses, gross
margins and inventory levels, potential shortages of components,
competition, the timing of regulatory approvals, the implementation,
including any modification, of the Company's strategic operating plans,
risks and uncertainties associated with implementing our acquisition
strategy and the ability to integrate acquired companies or selected
assets into our consolidated business operations, as well as the risks
discussed under the heading "Risk Factors" in Luminex's Reports on Forms
10-K and 10-Q, as filed with the Securities and Exchange Commission. The
forward-looking statements contained herein represent the judgment of
Luminex as of the date of this press release, and Luminex expressly
disclaims any intent, obligation or undertaking to release publicly any
updates or revisions to any forward- looking statements to reflect any
change in Luminex's expectations with regard thereto or any change in
events, conditions or circumstances on which any such statements are
based.